NRIX ▼ -0.2% - Nurix Therapeutics, Inc.
$NRIX - Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
05-OCT-2026 07:00 AM ET
Share this post
More filings for $NRIX
NRIX ▲ +0.0% - Nurix Therapeutics, Inc.Sep 29, 2026NRIX - Nurix Therapeutics, Inc. - SEC Filing Update (23-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 23, 2026NRIX - Nurix Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026NRIX - Nurix Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026$NRIX SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026
View full $NRIX filing history →💬 Comments
Loading comments…
Leave a comment